Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects

NCT05540912 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: D064+D701
DRUG: CKD-828 Formulation 1
DRUG: CKD-828 Formulation 2

Sponsor

Chong Kun Dang Pharmaceutical